Valproate embryopathy in three sets of siblings: Further proof of hereditary susceptibility
- 27 August 2002
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 59 (4) , 630-633
- https://doi.org/10.1212/wnl.59.4.630
Abstract
The fetal valproate syndrome (FVS) is characterized by distinctive facial appearance, major and minor malformations, and developmental delay. Generally, only a small proportion of prenatally exposed children are affected. The authors describe three families in whom the occurrence of FVS in all the siblings strongly suggests hereditary susceptibility to valproic acid-induced adverse outcome. The risk for recurrence in a subsequent pregnancy may be high and should be taken into account in the counseling of parents and in considering drug treatment.Keywords
This publication has 9 references indexed in Scilit:
- The Teratogenicity of Anticonvulsant DrugsNew England Journal of Medicine, 2001
- Valproic acid embryopathy: Report of two siblings with further expansion of the phenotypic abnormalities and a review of the literatureAmerican Journal of Medical Genetics, 2001
- Antiepileptic drug regimens and major congenital abnormalities in the offspringAnnals of Neurology, 1999
- Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapyJournal of the Neurological Sciences, 1997
- Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcomeActa Paediatrica, 1996
- Antiepileptic DrugsNew England Journal of Medicine, 1996
- Fetal valproate syndrome.Journal of Medical Genetics, 1995
- Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyPublished by Elsevier ,1991
- Intelligence of children of epileptic mothersThe Journal of Pediatrics, 1988